Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
abuse, acid, ACS, al, amide, analgesic, anandamide, andin, anniversary, benchmark, binomial, Bristol, broker, cannabanoid, cannabinoid, capped, colon, corroboration, counted, CT, custodial, custodian, customary, daily, default, dictate, encourage, ensuing, enzyme, excellent, expressly, FAAH, fatty, fraud, harvest, Herceptin, hydrochlorideINGIST, hydrolase, imposition, indirectly, insignificant, invasive, justify, lender, lowest, malate, mesylate, monotherapy, mortgage, Mundipharma, nerve, neuropathic, Nilsson, occurrence, pain, paper, pharmacodynamic, plasma, PPLP, prime, proper, propertiesin, Purdue, randomized, ratio, reacquired, reacquisition, recurrent, regression, relief, repay, reset, RING, short, statute, steering, stroma, subordinate, subtype, tail, thereunder, thrive, tiered, trastuzumab, tyrosine, unaddressed, unadjusted, unobservable, unplanned, unsecured, weather, xenograft
Removed:
Abbott, accelerated, add, agree, category, communication, decade, deliver, depth, desire, disclose, ease, enabled, evolve, expend, innovation, integrate, internally, maximize, metabolic, operational, optimized, potency, producing, reach, reclassified, requiring, solubility, specificity, whichever
Filing tables
Filing exhibits
- 10-K Annual report
- 10.1 Strategic Alliance Agreement Between Registrant and Purdue Pharmaceutical
- 10.2 Strategic Alliance Agreement Between Registrant and Mundipharma International
- 21.1 Subsidiaries of the Registrant
- 23.1 Consent of Ernst & Young LLP
- 31.1 Certification of Principal Executive Officer Pursuant to Section 302
- 31.2 Certification of Principal Financial Officer Pursuant to Section 302
- 32.1 Certification of Principal Executive Officer Pursuant to Section 906
- 32.2 Certification of Principal Financial Officer Pursuant to Section 906
Related press release
INFIQ similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (Form S-3 Nos. 333-156246 and 333-139641 and Form S-8 Nos. 333-156641, 333-151135, 333-145306 and 333- 138248) of Infinity Pharmaceuticals, Inc. and in the related Prospectuses of our reports dated March 11, 2009, with respect to the consolidated financial statements of Infinity Pharmaceuticals, Inc., and the effectiveness of internal control over financial reporting of Infinity Pharmaceuticals, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2008.
/s/ Ernst & Young LLP |
Boston, Massachusetts
March 11, 2009